Groups | Covid-19 | Control | P-value |
---|---|---|---|
(N = 77) | (N = 322) | ||
Variables | Mean ± SD, Number (%) | Mean ± SD, Number (%) | |
Interventions on admission | |||
Thrombectomy | 3 (3.9%) | 15 (4.7%) | 0.99 |
Alteplase | 12 (15.6%) | 59 (18.3%) | 0.62 |
Antiplatelet | 42 (54.5%) | 174 (54%) | 0.94 |
Anticoagulant | 10 (13%) | 21 (6.5%) | 0.09 |
Stroke onset hours | 5.7 ± 3.8 | 5.2 ± 2.1 | 0.12 |
Stroke territory | |||
Anterior circulation | 46 (59.74%) | 218 (67.7%) | 0.52 |
Posterior circulation | 24 (31.1%) | 76 (23.6%) | |
Multiple territory | 7(9.1%) | 28(8.7%) | |
Stroke mechanism | |||
Small arteries | 19 (24.7%) | 86 (26.7%) | |
Large vessels | 21 (27.3%) | 68 (21.1%) | 0.69 |
Cardio-embolic | 3 (3.9%) | 12 (3.7%) | |
Other | 34 (44.2%) | 156 (48.4%) | |
Fits with stroke | 9 (11.7%) | 17 (5.3%) | 0.07 |